InsiderClue
← All stocks

RenovoRx, Inc.

RNXT Net buying
CIK 0001574094 #4619 in the set updated 20 Sep 2026
Bought (120 mo)
$264.94K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$264.94K
+$264.94K against sales at will

By person

9 insiders · 38 transactions
0.8×

Shaun R. Bagai holds only 0.8 times base salary in stock. $514.62K of shares against $583.44K in salary for 2025.

Salary from the company's own proxy. The shares are what Shaun R. Bagai last reported holding, valued at $0.79, the price Common Stock was last bought or sold at on the open market here, on 19 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Agah Ramtin
Chief Medical Officer
$171.11K (14)
—
+$171.11K
1,773,460
3.93%
$1.40M
−9.1%
Bagai Shaun
Chief Executive Officer
$52.76K (10)
—
+$52.76K
653,397
1.45%
$514.62K
+22.1%
VOLL MARK
Chief Financial Officer
$19.69K (2)
—
+$19.69K
416,780
0.9235%
$328.26K
+241.1%
Marton Laurence
Director
$10.22K (3)
—
+$10.22K
75,884
0.1681%
$59.77K
—
Kocak Ron
VP, Controller and PAO
$10.01K (3)
—
+$10.01K
12,595
0.0279%
$9.92K
—
Nelms Angela
Chief Operating Officer
$1.15K (2)
—
+$1.15K
1,100
0.0024%
$866.36
—
Macfarlane K. Angela
Director
— (1)
—
$0.00
40,983
0.0908%
$32.28K
—
Spiegel Robert J.
Director
— (1)
—
$0.00
40,983
0.0908%
$32.28K
—
RYAN UNA S
Director
—
—
—
97,165
0.2153%
$76.53K
—

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
Marton Laurence
2 May 2025
Director
Exercised, kept
20,480
$0.15
$3.07K
Marton Laurence
3 Nov 2022
Director
Exercised, kept
25,438
$1.70
$43.24K
Show all 38 transactions →

What was left out

Form 4 filings counted 89
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 8
Shares from compensation/vesting 2,666,758
History held since 4 Oct 2021